Gallbladder Cancer Global Clinical Trials Review, H2, 2017

2017-08-23
Price :
Published : Aug-2017
No. of Pages : 181

Gallbladder Cancer Global Clinical Trials Review, H2, 2017

Summary

GlobalData’s clinical trial report, “Gallbladder Cancer Global Clinical Trials Review, H2, 2017” provides an overview of Gallbladder Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Gallbladder Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope
– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy
– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Filed in: Pharmaceutical
Publisher : GlobalData
More Reports
Title Price Buy Now

Mymetics Corp (MYMX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Mymetics Corp (Mymetics) is a biotechnology company that develops next-generation prophylactic vaccines for infectious diseases. The company's product pipeline includes vaccine candidates that target HIV-1/AIDS, chikungunya, intranasal influenza, malaria, herpes simplex virus (HSV) and respiratory syncytial virus (RSV). Mymetics uses its proprietary technology which deploys virosomes and lipid-based carriers containing viral proteins and natural membrane proteins, in combination with rationally designed antigens or adjuvants to develop vaccines. Its vaccines are designed to induce protection against early transmission and infection. The company has subsidiaries in the Netherlands and Switzerland. It has a research and development facility in Leiden, the Netherlands. Mymetics is ......
$250

St. George’s University of London – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary St. George's University of London (SGUL), a subsidiary of University of London is a medical and healthcare education provider that offers undergraduate and post graduate courses. The university's undergraduate courses include biomedical science BSc, healthcare practice DipHE and BSc, healthcare practice foundation degree, biomedical science foundation degree, breast imaging foundation degree, healthcare science and medicine MBBS. It provides post graduate courses such as biomedical science MRes, clinical practice MRes, medical imaging, nursing, oncology practice PgCert, physician associate studies postgraduate diploma, physiotherapy MSc and social work PgDip. SGUL conducts research in the field of cardiovascular and cell sciences, infection and immunity and population health. Th......
$250

Eunice Kennedy Shriver National Institute of Child Health and Human Development – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), a subsidiary of National Institutes of Health is a research institute that conducts and supports laboratory research, clinical trials, and epidemiological studies. The institute conducts research in the fields of fields of reducing infant deaths, improving health of women, men and families learning. It offers research in clinical trials and clinical research, health education campaigns and programs, NICHD publications, scientific research planning and scientific resources. NICHD also provides funding support for training and career development activities at universities and other institutions. The institute offers its services for laboratory research, clinical trials and studies. NICHD is he......
$250

Takeda Pharmaceuticals USA Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Takeda Pharmaceuticals USA Inc (TPUSA), formerly Takeda Pharmaceuticals North America Inc, a subsidiary of Takeda Pharmaceutical Company Ltd, is a developer, manufacturer and distributor of pharmaceutical drugs. The company's products include pioglitazone and glimepiride, lubiprostone, pioglitazone, pioglitazone and metformin HCl, azilsartan medoxomil, alogliptin, peginesatide, lansoprazole, colchicine, USP, dexlansoprazole, ramelteon and febuxostat. It offers products in therapeutic areas including cardiovascular disease, central nervous system disorders, bone and joint disorders, gastroenterology, gynecology disorders, kidney disorders and other infectious diseases. TPUSA conducts research and development activities to develop new drugs. The company markets its products throug......
$250

EnGeneIC Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary EnGeneIC Ltd (EnGeneIC) is a biopharmaceutical company that develops drugs and other therapeutic molecules. The company develops nanocell platform used as a platform for the creation of custom therapies for cancer. Its cyto-immunotherapy platform releases concentrations of RNA-interference molecules, chemotherapeutic agents, and molecularly targeted drugs into targeted tumor cells. EnGeneIC's technologies include targeted drug delivery, EnGeneIC dream vector technology, targeted small interfering RNA delivery and targeted microRNA delivery. The company offers preclinical development and clinical trial services. It develops proprietary EDV nanocell platform for the delivery of chemotherapeutics and functional nucleic acids in cancer. The company operates in Lane Cove West, Austra......
$250

Fate Therapeutics Inc (FATE) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Fate Therapeutics Inc (Fate Therapeutics) is a biopharmaceutical company that develops programmed cellular therapies for cancer and immune disorders. The company's pipeline product candidates include cellular immunotherapy pipeline, immuno-oncology candidates, and immuno-regulatory candidates. Its immuno-oncology product candidates include adaptive NK, pluripotent cell-derived cancer immunotherapies, and engineered CAR and TCR T- cell immunotherapies. Its products are derived from pluripotent cells. Fate Therapeutics uses ex vivo cell programming approach to include cell-surface proteins, rapid and supra-physiologic activation or inhibition of therapeutically-relevant genes, and to regulate the therapeutic function. The company's immuno-regulatory cellular therapies promote immu......
$250

NanoString Technologies Inc (NSTG) – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary NanoString Technologies Inc (NanoString) is a provider of life science products and tools for translational research and molecular diagnostics. The company's products portfolio includes sprint profiler, Dx analysis system with flex, MAX analysis system, protein assays, solid tumor assays, gene fusion panels, RNA panels, DNA assays, immunology panel, gene expression codesets, pancancer immune profiling and pathways among others. NanoString's nCounter analysis system provides cost-effective method to profile hundreds of miRNA, miRGE or DNA molecules simultaneously employing digital molecular barcoding technology. The company sells its products through direct sales force and distributors in the US, Europe, the Middle East and Asia-Pacific. NanoString is headquartered in Seattle, Wa......
$250

Ferndale Pharma Group Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Ferndale Pharma Group Inc (Ferndale Pharma), formerly Ferndale Laboratories Inc is a manufacturer and distributor of pharmaceutical products. The company provides surgical instruments, medical supplies, skin care products, topical therapeutic products, prescription, over the counter products, and equipment to the medical profession. It offers contract manufacturing services such as pharmaceutical production, quality assurance, quality control, product development, warehousing, and distribution services. Ferndale Pharma serves to hospitals, healthcare practitioners, and patients. The company supplies skin care and topical therapeutic products for hospitals, pharmacies, and aesthetic professionals and their client. It operates in the US, and the UK. Ferndale Pharma is headquartere......
$250

Genedata AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Genedata AG (Genedata) is a healthcare technology company that transforms data into software solutions. The company delivers enterprise solutions for data analytics that streamline research and development workflows and improve research productivity. Its products include genedata biologics, genedata screener, genedata expressionist, genedata philosopher, genedata analyst and genedata selector. Genedata provides services such as information technology services, data analysis, custom software development, training, and hosting. The company also offers support and training services. It serves pharma, bio-pharma, agribusiness, industrial biotech, food and beverage, and other sectors. The company has presence in Switzerland, Germany, the US and Japan. Genedata is headquartered in Bas......
$250

Histogen Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile

Summary Histogen Inc (Histogen) is a regenerative medicine company that develops novel therapies. The company offers research and develops cell based products. Its products include insoluble human extracellular matrix and a soluble complex of proteins. Histogen's proprietary technologies are used in various applications which include hair regrowth and skincare; therapeutics including orthopedics and oncology. The company's products are stabilized and bioactive in a biocompatible liquid formula. Its products are used as research tools for stem cell growth and therapeutics. It offers products to biotechnology companies and medical research institutes. Histogen is headquartered in San Diego, California, the US. Histogen Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile pr......
$250